Preparation and characterization of chitosan microspheres for controlled release of synthetic oligopeptide derived from BMP-2

References

• Keller S, Nickel J, Zhang JL, Sebald W, Mueller TD. Molecular recognition of BMP-2 and BMP receptor IA. Nat Struct Mol Biol 2004; 11: 481–8
   PubMed Web of Science ®Google Scholar
• Lin SJ, Lerch TF, Cook RW, Jardetzky TS, Woodruff TK. The structural basis of TGF-β, bone morphogenetic protein, and activin ligand binding. Reproduction 2006; 132: 179–90
   PubMed Web of Science ®Google Scholar
• Chen FM, Zhao YM, Zhang R, Jin T, Sun HH, Wu ZF, et al. Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins. J Contr Rel 2007b; 121: 81–90
   PubMed Web of Science ®Google Scholar
• Kim CS, Kim JI, Kim J, Choi SH, Chai JK, Kim CK, et al. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005; 26: 2501–7
   PubMed Web of Science ®Google Scholar
• Hosseinkhani H, Hosseinkhani M, Khademhosseini A, Kobayashi H. Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J Contr Rel 2007; 117: 380–6
   PubMed Web of Science ®Google Scholar
• Saito N, Takaoka K. New synthetic biodegradable polymers as BMP carriers for bone tissue engineering. Biomaterials 2003; 24: 2287–93
   PubMed Web of Science ®Google Scholar
• Wozney JM, Seeherman HJ. Protein-based tissue engineering in bone and cartilage repair. Curr Opin Biotech 2004; 15: 392–98
   PubMed Web of Science ®Google Scholar
• Chadderdon RC, Shimer AL, Gilbertson LG, Kang JD. Advances in gene therapy for intervertebral disc degeneration. Spine J 2004; 4: 341S–7S
   PubMedGoogle Scholar
• Kirsch T, Sebald W, Dreyer MK. Crystal structure of the BMP-2-BRIA ectodomain complex. Nat Struct Biol 2000; 7: 492–6
   PubMedGoogle Scholar
• Saito A, Suzuki Y, Ogata S, Ohtsuki C, Tanihara M. Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. Biochim Biophys Acta 2003; 1651: 60–7
   PubMed Web of Science ®Google Scholar
• Duan Z, Zheng Q, Guo X, Yuan Q, Chen S. Experimental research on ectopic osteogenesis of BMP2-derived peptide P24 combined with PLGA copolymers. J Huazhong Uni Sci Technol 2007; 27: 179–82
   PubMedGoogle Scholar
• Yuan Q, Guo X, Zheng Q, Zhao M, Pan Z, Chen S, et al. Bioinspired growth of hydroxyapatite nanocrystals on PLGA-(PEG-ASP)n scaffolds modified with oligopeptide derived from BMP-2. Key Eng Mater 2007; 334–335: 1261–4
   Google Scholar
• Wang LY, Ma GH, Su ZG. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug. J Contr Rel 2005; 106: 62–75
   PubMed Web of Science ®Google Scholar
• Chen FM, Wu ZF, Sun HH, Wu H, Xin SN, Wang QT, et al. Release of bioactive BMP from dextran-derived microspheres: a novel delivery concept. Int J Pharm 2006; 307: 23–32
   PubMed Web of Science ®Google Scholar
• Chen FM, Zhao YM, Sun HH, Jin T, Wang QT, Zhou W, et al. Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics. J Contr Rel 2007a; 118: 65–77
   PubMed Web of Science ®Google Scholar
• Desai KGH, Park HJ. Encapsulation of vitamin C in tripolyphosphate cross-linked chitosan microspheres by spray drying. J Microencapsulation 2005a; 22: 179–92
   PubMed Web of Science ®Google Scholar
• Varshosaz J. The promise of chitosan microspheres in drug delivery systems. Expert Opin 2007; 4: 263–73
   Google Scholar
• Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, et al. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004; 274: 1–33
   PubMed Web of Science ®Google Scholar
• Desai KG, Park HJ. Effect of manufacturing parameters on the characteristics of vitamin C encapsulated tripolyphosphate-chitosan microspheres prepared by spray-drying. J Microencapsulation 2006; 23: 91–103
   PubMed Web of Science ®Google Scholar
• Xu Y, Hanna MA. Electrosprayed bovine serum albumin-loaded tripolyphosphate cross-linked chitosan capsules: synthesis and characterization. J Microencapsulation 2007; 24: 143–51
   PubMed Web of Science ®Google Scholar
• Knaul JZ, Hudson SM, Creber KAM. Improved mechanical properties of chitosan fibers. J Appl Polym Sci 1999; 72: 1721–32
   Web of Science ®Google Scholar
• Wei G, Jin Q, Giannobile WV, Ma PX. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J Contr Rel 2006; 112: 103–10
   PubMed Web of Science ®Google Scholar
• Wei G, Jin Q, Giannobile WV, Ma PX. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 2007; 28: 2087–96
   PubMed Web of Science ®Google Scholar
• Baldwin SP, Mark Saltzman W. Materials for protein delivery in tissue engineering. Adv Drug Deliv Rev 1998; 33: 71–86
   PubMed Web of Science ®Google Scholar
• Lee JE, Kim SE, Kwon IC, Ahn HJ, Cho H, Lee SH, et al. Effects of a chitosan scaffold containing TGF-β1 encapsulated chitosan microspheres on in vitro chondrocyte culture. Artif Organs 2004a; 28: 829–39
   PubMed Web of Science ®Google Scholar
• Lee SH, Shin H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 2007; 59: 339–59
   PubMed Web of Science ®Google Scholar
• Sun JS, Lin FH, Wang YJ, Huang YC, Chueh SC, Hsu FY. Collagen-hydroxyapatite/tricalcium phosphate microspheres as a delivery system for recombinant human transforming growth factor-β1. Artif Organs 2003; 27: 605–12
   PubMed Web of Science ®Google Scholar
• DeFail AJ, Chu CR, Izzo N, Marra KG. Controlled release of bioactive TGF-β1 from microspheres embedded within biodegradable hydrogels. Biomaterials 2006; 27: 1579–85
   PubMed Web of Science ®Google Scholar
• Kim SE, Park JH, Cho YW, Chung H, Jeong SY, Lee EB, et al. Porous chitosan scaffold containing microspheres loaded with transforming growth factor-β1: implications for cartilage tissue engineering. J Contr Rel 2003; 91: 365–74
   PubMed Web of Science ®Google Scholar
• Lee JE, Kim KE, Kwon IC, Ahn HJ, Lee SH, Cho H, et al. Effects of the controlled-released TGF-β1 from chitosan microspheres on chondrocytes cultured in a collagen/chitosan/glycosaminoglycan scaffold. Biomaterials 2004b; 25: 4163–73
   PubMed Web of Science ®Google Scholar
• Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm 2002; 249: 165–74
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int J Pharm 2002; 233: 217–225
   PubMed Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. J Microencapsulation 2001; 18: 237–45
   PubMed Web of Science ®Google Scholar
• Desai KGH, Park HJ. Preparation of cross-linked chitosan microspheres by spray drying: effect of cross-linking agent on the properties of spray dried microspheres. J Microencapsulation 2005b; 22: 377–95
   PubMed Web of Science ®Google Scholar
• Desai KG, Liu C, Park HJ. Characteristics of vitamin C encapsulated tripolyphosphate-chitosan microspheres as affected by chitosan molecular weight. J Microencapsulation 2006; 23: 79–90
   PubMed Web of Science ®Google Scholar
• Cai DZ, Zeng C, Quan DP, Bu LS, Wang K, Lu HD, et al. Biodegradable chitosan scaffolds containing microspheres as carriers for controlled transforming growth factor-β1 delivery for cartilage tissue engineering. Chin Medl J 2007; 120: 197–203
   PubMed Web of Science ®Google Scholar
• Tabata Y, Ikada Y. Protein release from gelatin matrices. Adv Drug Deliv Rev 1998; 31: 287–301
   PubMed Web of Science ®Google Scholar
• Lu L, Stamatas GN, Mikos AG. Controlled release of transforming growth factor β1 from biodegradable polymer microparticles. J Biomed Mater Res 2000; 50: 440–51
   PubMed Web of Science ®Google Scholar
• Lu L, Yaszemski MJ, Mikos AG. TGF-β1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. J Bone Joint Surg Am 2001; 83(S1)82–91
   Google Scholar
• Peter SJ, Lu L, Kim DJ, Stamatas GN, Miller MJ, Yaszemski MJ, et al. Effects of transforming growth factor β1 release from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res 2000; 50: 452–62
   PubMed Web of Science ®Google Scholar